Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Soluble guanylyl cyclase (sGC) is the known receptor for nitric oxide. The binding of nitric oxide to the heme moiety of the cyclase induces its capacity to synthesize the second messenger cGMP.
The sGC pipeline drugs market research report provides comprehensive information on the therapeutics under development for sGC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report reviews key players involved in therapeutic development for sGC and features dormant and discontinued projects.
sGC Pipeline Drugs Market Segmentation by Mechanism of Actions
The key mechanisms of action of the sGC pipeline drugs market are Soluble Guanylate Cyclase Activator and Soluble Guanylate Cyclase Inhibitor.
sGC Pipeline Drugs Market Analysis, by Mechanism of Actions, 2022 (%)
For more MoA insights into the sGC pipeline drugs market, download a free report sample
sGC Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the sGC pipeline drugs market are oral, inhalational, ophthalmic, parenteral, and topical.
sGC Pipeline Drugs Market Analysis, by Routes of Administration, 2022 (%)
For more RoA insights into the sGC pipeline drugs market, download a free report sample
sGC Pipeline Drugs Market Segmentation by Molecule Types
The key molecule types in the sGC pipeline drugs market are small molecule, protein, and synthetic peptide.
sGC Pipeline Drugs Market Analysis, by Molecule Types, 2022 (%)
For more molecule type insights into the sGC pipeline drugs market, download a free report sample
sGC Pipeline Drugs Market - Competitive Landscape
Some of the leading companies in the sGC pipeline drugs market are Bayer AG, Akebia Therapeutics Inc, AntiRadical Therapeutics LLC, Boehringer Ingelheim International GmbH, Cyclerion Therapeutics Inc, and Gurus BioPharm Inc.
sGC Pipeline Drugs Market Analysis, by Companies, 2022 (%)
To know more about the companies in the sGC pipeline drugs market, download a free report sample
sGC Pipeline Drugs Market Report Overview
Key Mechanism of Actions | Soluble Guanylate Cyclase Activator and Soluble Guanylate Cyclase Inhibitor |
Key Routes of Administration | Oral, Inhalational, Ophthalmic, Parenteral, and Topical |
Key Molecule Types | Small Molecule, Protein, and Synthetic Peptide |
Leading Companies | Akebia Therapeutics Inc, AntiRadical Therapeutics LLC, Bayer AG, Boehringer Ingelheim International GmbH, Cyclerion Therapeutics Inc, and Gurus BioPharm Inc |
Segments Covered in the Report
sGC Pipeline Drugs Market Mechanism of Actions Outlook
- Soluble Guanylate Cyclase Activator
- Soluble Guanylate Cyclase Inhibitor
sGC Pipeline Drugs Market Routes of Administration Outlook
- Oral
- Inhalational
- Ophthalmic
- Parenteral
- Topical
sGC Pipeline Drugs Market Molecule Types Outlook
- Small Molecule
- Protein
- Synthetic Peptide
Scope
This report provides:
- A snapshot of the global therapeutic landscape of sGC.
- Reviews of pipeline therapeutics for sGC by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which comprise product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- Reviews of key companies involved in sGC therapeutics and enlists all their major and minor projects.
- Evaluation of sGC therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news related to pipeline therapeutics for sGC.
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
- Identify and understand the targeted therapy areas and indications for Soluble Guanylate Cyclase
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding the Soluble Guanylate Cyclase development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
AntiRadical Therapeutics LLC
Bayer AG
Boehringer Ingelheim International GmbH
Cyclerion Therapeutics Inc
Gurus BioPharm Inc
Innovative Pharmacology Research
Merck & Co Inc
NicOx SA
Nitric Oxide Innovations LLC
Novartis AG
Novoteris LLC
Toa Eiyo Ltd
Topadur Pharma AG
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key mechanisms of action in the sGC pipeline drugs market?
The key mechanisms of action in the sGC pipeline drugs market are Soluble Guanylate Cyclase Activator and Soluble Guanylate Cyclase Inhibitor.
-
What are the key routes of administration in the sGC pipeline drugs market?
The key routes of administration in the sGC pipeline drugs market are oral, inhalational, ophthalmic, parenteral, and topical.
-
What are the key molecule types in the sGC pipeline drugs market?
The molecule types in the sGC pipeline drugs market are small molecule, protein, and synthetic peptide.
-
Which are the leading companies in the sGC pipeline drugs market?
The key companies in the soluble guanylate cyclase pipeline market are Akebia Therapeutics Inc, AntiRadical Therapeutics LLC, Bayer AG, Boehringer Ingelheim International GmbH, Cyclerion Therapeutics Inc, Gurus BioPharm, Innovative Pharmacological Research (IPHAR) Co Ltd, Merck & Co Inc, NicOx SA, Nitric Oxide Innovations LLC, and Novan Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.